Headlines about Allscripts Healthcare Solutions (NASDAQ:MDRX) have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Allscripts Healthcare Solutions earned a news sentiment score of 0.22 on Accern’s scale. Accern also gave media headlines about the software maker an impact score of 46.3560862300584 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the news stories that may have impacted Accern’s analysis:
Allscripts Healthcare Solutions (NASDAQ MDRX) traded up $0.09 during trading hours on Wednesday, hitting $14.41. 2,397,825 shares of the stock were exchanged, compared to its average volume of 2,346,532. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.98 and a current ratio of 0.98. Allscripts Healthcare Solutions has a 12 month low of $10.19 and a 12 month high of $14.65. The company has a market cap of $2,578.32, a price-to-earnings ratio of 33.19, a P/E/G ratio of 2.54 and a beta of 1.34.
Several analysts recently commented on the stock. Zacks Investment Research downgraded shares of Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, November 8th. SunTrust Banks reissued a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a report on Friday, November 3rd. Maxim Group reissued a “buy” rating and issued a $16.00 price objective on shares of Allscripts Healthcare Solutions in a report on Friday, November 3rd. Robert W. Baird boosted their target price on shares of Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the company an “outperform” rating in a research report on Friday, November 3rd. Finally, KeyCorp restated a “hold” rating on shares of Allscripts Healthcare Solutions in a research report on Friday, October 27th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and eleven have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $15.06.
In related news, EVP Brian Farley sold 5,000 shares of the stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total transaction of $67,600.00. Following the transaction, the executive vice president now directly owns 196,607 shares of the company’s stock, valued at $2,658,126.64. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP James Hewitt sold 36,796 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $14.11, for a total transaction of $519,191.56. Following the transaction, the senior vice president now directly owns 181,766 shares in the company, valued at $2,564,718.26. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 71,796 shares of company stock worth $992,992. Insiders own 0.91% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This story was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/14/allscripts-healthcare-solutions-mdrx-earns-media-impact-score-of-0-22.html.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.